These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience? Sicard A; Kanitakis J; Dubois V; Morelon E; Thaunat O Transplantation; 2020 Oct; 104(10):2003-2010. PubMed ID: 32039965 [TBL] [Abstract][Full Text] [Related]
25. Vascularized Brachial Plexus Allotransplantation-An Experimental Study in Brown Norway and Lewis Rats. Chang TN; Chen KT; Gorden T; Daniel BW; Hernon C; Shafarenko M; Huang YL; Lu JC; Chuang DC Transplantation; 2019 Jan; 103(1):149-159. PubMed ID: 30048401 [TBL] [Abstract][Full Text] [Related]
30. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714 [TBL] [Abstract][Full Text] [Related]
31. Scabies in a bilateral hand allograft recipient: An additional mimicker of acute skin rejection in vascularized composite allotransplantation. Kanitakis J; Morelon E Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28211139 [TBL] [Abstract][Full Text] [Related]
32. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation. Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877 [TBL] [Abstract][Full Text] [Related]
33. Regulatory oversight in the United States of vascularized composite allografts. Glazier AK Transpl Int; 2016 Jun; 29(6):682-5. PubMed ID: 26284312 [TBL] [Abstract][Full Text] [Related]
34. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation. Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? Howsare M; Jones CM; Ramirez AM Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463 [TBL] [Abstract][Full Text] [Related]
36. Bone vascularized composite allotransplantation model in swine tibial defect: Evaluation of surgical angiogenesis and transplant viability. Kotsougiani D; Hundepool CA; Bulstra LF; Friedrich PF; Shin AY; Bishop AT Microsurgery; 2019 Feb; 39(2):160-166. PubMed ID: 29504151 [TBL] [Abstract][Full Text] [Related]
37. A chronic rejection model and potential biomarkers for vascularized composite allotransplantation. Puscz F; Dadras M; Dermietzel A; Jacobsen F; Lehnhardt M; Behr B; Hirsch T; Kueckelhaus M PLoS One; 2020; 15(6):e0235266. PubMed ID: 32589662 [TBL] [Abstract][Full Text] [Related]
38. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine. Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743 [TBL] [Abstract][Full Text] [Related]